The present invention provides methods, compositions and uses for treating topical bacterial infections comprising the administration of cannabinoids. In particular, the present invention provides methods, uses and compositions for treating bacterial infections, the compositions comprising cannabidiol or other cannabinoids, in a dose ranging from about 25 mg to about 500 mg of the cannabinoid compounds.

The present invention relates to a cannabinoid containing oral solution. Preferably the oral solution comprises a cannabinoid, a lipid solvent, a sweetener and ethanol, characterised in that the sweetener is an ultrahigh potency sweetener.

Described herein are therapeutic beverages that include a beverage type liquid medium and a plurality of spherical- and/or spheroidal-shaped particles dispersed within the liquid medium, wherein the plurality of the spherical- and/or spheroidal-shaped particles comprise at least one active pharmaceutical ingredient (API) disposed within the plurality of the spherical- and/or spheroidal-shaped particles. Also, described herein are methods of producing the described therapeutic beverages.

Methods of stabilizing acidic cannabinoids by intercalating the acidic cannabinoids into layered double hydroxides (LFHs) are provided. Also provided are compositions comprising the LDH-intercalated acidic cannabinoids, physiologically compatible formulations comprising the compositions and methods of using the formulations to treat a variety of diseases and conditions in subjects.

Formulations for pain treatment include an effective amount of liquid composition comprised of CBD, oftentimes CBG and CBN, sometimes CBC and THC, and a nominal effective amount of at least two terpenes from the group of terpenes including beta caryophyllene (CAR), α-pinene, β-pinene, limonene (LIM), linalool (LOL), myrcene (MYR), nerolidol (NRD), humulene (HUM), and terpinolene (TPN). For insomnia/nighttime pain: CBD, oftentimes CBG/CBN, sometimes THC, and nominal CAR, LEVI, LOL, MYR, NRD and TPN. For anxiety #1 (Calm): CBD, oftentimes CBG/CBN, sometimes THC, and nominal CAR, LEVI, LOL, MYR, and NRD. For anxiety #2 (Serenity), alter #1 and add α-pinene, β-pinene, HUM and TPN. For GI relief, CBD, oftentimes CBG/CBN, sometimes THC, and nominal ALL nominal CAR, α-pinene, LEVI, LOL, MYR, and NRD. Other formulations are provided for relief of: insomnia due to pain, anxiety, etc.; neurodegenerative diseases; headaches, migraines and associated nausea and vomiting; autism; and cancer and cancer treatment-related symptoms.

An object of the present invention is to improve the intake efficiency of cannabidiol (CBD). The above object can be achieved by a seamless soft capsule comprising a capsule film, and a content enclosed in the capsule film, wherein the content contains cannabidiol.

Methods and formulations for providing efficacious pain relief by transdermal delivery of cannabidiol (CBD), the formulations having a high weight ratio of CBD to (−)-trans-Δ.sup.9-tetrahydrocannabinol (THC).

The present invention provides compositions and methods for treating or preventing a gram-positive bacterial infection. In one aspect, the composition comprises at least two cannabinoids.

Compositions including cannabinoid and use thereof are provided in the present disclosure. In some embodiments, the composition may include cannabidiol (CBD), cannabigerol (CBG), and bakuchiol (BAK). A molar concentration ratio of CBD, CBG, and BAK may be 1:1:1 in the composition. A molar concentration of CBD in the composition may be in a range of 1.67 μM to 16.7 μM.

The present invention concerns a solid oral dosage form comprising albumin and at least one cannabinoid, wherein the oral dosage form is free of a gas generating agent (GGA) and wherein the oral dosage form is prepared using a compression force Q of below 1 ton.